News Releases

The 8th Annual Biotech Showcase™ will celebrate life sciences innovations in January 2016 amid the largest healthcare investor conference of the year

CARLSBAD, Calif. and NEW YORK and SAN FRANCISCO, Nov. 10, 2015 /PRNewswire/ -- The eighth annual Biotech Showcase™ investor and networking conference will be held January 11–13, 2016 in San Francisco, CA at Parc 55 San Francisco - A Hilton Hotel. The event is expected to bring together 2,100+ attendees representing the life science industry's most enterprising and pioneering biotech companies and major players in the drug development arena.

The primary draw of the event is to bring together public, private and strategic investors with cutting edge public and private biotechnology and life science companies, including regenerative medicine and advanced therapies, platform and tool companies, research focused service providers, molecular diagnostic companies, personalized medicine and small and large molecule R&D therapeutic companies.

New this year are two new one-day programs in 2016.  Medtech Showcase and Digital Health Showcase. Medtech Showcase will be held on January 12 and is designed to connect innovative medtech companies with investors. It will feature 30+ presentations from innovative medtech companies and a state of the industry report from leading executives in the space. Digital Health Showcase will be held on January 13 and features select company presentations focusing on digital therapeutics that intersect technology and medicine.

Other highlights of the event include:

  • More than 250 presentations by innovative mid-small cap and private life sciences companies
  • Investors looking for new investment opportunities
  • Top-notch C-level speakers on plenary sessions and workshops
  • 4,200+ dedicated one-to-one meetings during one of the industry's largest annual healthcare investor conferences.

"Biotech Showcase continues to reign as a top investor conference for mid- to small-cap and private biotech companies during healthcare's busiest week of the year," said Sara Jane Demy, CEO of Demy-Colton Life Science Advisors. "It is the only conference where you will find such a large number of investors in the life sciences space in one place, looking to hear from and meet management teams of the industry's most innovative companies."

"We have added some new features to this year's event to meet market demand," said Anna Chrisman, Group Managing Director, EBD Group. "We have expanded the program to offer two new dedicated days for medtech and digital health, and we have also expanded our meeting space to enable more one-to-one meetings."

The 2015 edition had 232 company presentations and attracted more than 2,100 attendees from 1,276 companies who participated in nearly 4,300 one-to-one meetings.

Biotech Showcase is produced by Demy-Colton Life Science Advisors and EBD Group. Both organizations have a long history of producing high quality programs that support the biotechnology and broader life sciences industry.

Biotech Showcase is powered by partneringONE®, the industry's most advanced meeting system that enables delegates to efficiently identify and arrange meetings with potential investors.

Applications to present will be accepted on a rolling basis.

Follow Biotech Showcase 2016 on Twitter:  @EBDGroup (hashtag: #BTS16).

Online Press Kit service for Biotech Showcase 2016 is available from PR Newswire to enhance your public relations efforts.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group's conferences are run with the support of leading corporations and international trade associations and include:

For more information please visit

About Demy-Colton Life Science Advisors

Demy-Colton Life Science Advisors is focused exclusively on facilitating the growth of the life science industry. Demy-Colton has developed a number of high-value added conferences to address the business and development needs of the biotechnology industry; it provides partnering services and it has helped launch a unique investor website and newsletter.

Demy-Colton's conferences include:

For more information please visit



For further information: Erin Righetti, EBD Group, +1 760 930 0500,, or Media Contact, Andrew W. Mielach, Vice President, Tiberend Strategic Advisors, Inc., Direct 212-375-2694,